Biomedical Warming and Thawing Devices Market size is set to surpass USD 308 million by 2027, according to a new research report by Global Market Insights Inc.
Rising technological advancements in biomedical warming and thawing devices, surging automation level in research institutes, and increasing focus on R&D in stem cell banking are some of the key factors boosting the adoption of manual and automatic instruments for warming and thawing of cryopreserved samples. The use of an automatic thawing system to address the gap in the cell cryopreservation workflow has increased due to the advent of novel devices with multiple detection mechanisms to determine vial temperature, thaw completion, and phase change initiation. The rise in number of blood banks and blood transfusion centers across the globe is expected to be one of the major factors driving the market growth. According to the American Association for the Surgery of Trauma, in the U.S., trauma accounts for over 3 million non-fatal injuries per year. The rise in the number of trauma and road accident cases increases the need for blood transfusion, thereby augmenting the demand for biomedical warming and thawing devices that aid in the warming and thawing of blood products.
Growing number of blood banks and blood transfusion centers across the globe are predicted to stimulate the market expansion
Rising number of blood banks and blood transfusion centers worldwide are projected to spur the biomedical warming and thawing devices market demand during the forecast period. Blood transfusion is widely used in cases of anemia, surgical procedures, severe injuries, and sickle cell disorder among others. Thus, providing safe and adequate blood is an integral part of several countries national health care policy and infrastructure. For example, in Germany, blood transfusion services are provided by different organizations including the German Red Cross Blood Transfusion Services, the German Society for Transfusion Medicine and Immunohematology, etc. Similarly, the National Infusion Center Association in U.S. supports a network of nearly 200 organizations representing around 600 infusion centers throughout the country. The increasing awareness pertaining to blood donation, several government initiatives, and the rising prevalence of transfusion transmissible infection along with the growing burden of blood-borne ailments will boost the demand for blood banks, thereby propelling the industry expansion over the forecast timeframe.
Numerous benefits offered by manual warming and thawing devices are anticipated to enhance the market value
Get more details on this report - Request Free Sample PDF
The manual segment will to reach USD 202 million by 2027. This is primarily attributed to factors such as easy availability, lesser cost, and wide-ranging applications of manual warming and thawing devices among others. These devices use both agitation and controlled temperature to significantly decrease thaw times while ensuring the safety of the sample. The manual warming and thawing instruments are available in a range of sizes coupled with independent controls that accommodate a variety of configurations to meet specific needs, thereby stimulating the market progression. It allows thawing of separate orders at the same time along with other improved outcomes.
Browse key industry insights spread across 140 pages with 188 market data tables & 15 figures & charts from the report, “Biomedical Warming and Thawing Devices Market Size By Product (Manual, Automatic), By Sample (Blood Products, Ovum/Embryo, Semen), By End-use (Hospitals, Research Laboratories, Pharmaceutical Industry, Blood Banks and Transfusion Centers), COVID-19 Impact Analysis, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2021 – 2027” in detail along with the table of contents:
Growing awareness about availability of treatments for infertility is estimated to attract a large customer pool
The semen segment is set to witness 8.3% growth rate through 2027 owing to the increasing awareness regarding assisted reproduction, advancements in cryopreservation techniques, and easy access to infertility treatment among others. As per the American Association of Pregnancy, male infertility contributes to around 30% of the infertility cases that is around one-fifth of all infertility cases. Thus, supportive government policies in conjunction with an increase in funding for setting-up facilities across several countries are predicted to influence the demand for sperm banks, thereby augmenting the acceptance of biomedical warming and thawing devices for semen cryopreservation.
Emerging number of research laboratories implementing thawing systems for optimum outcomes is slated to fuel the market demand
The research laboratories end-use segment is poised to register 9% CAGR till 2027 impelled by the rising burden of chronic disorders, increasing demand for early and fast lab tests, growing healthcare expenditure, and the introduction of technologically advanced products among others. For example, in Germany, over 1000 publicly funded research laboratories are operating to conduct cellular and biochemical experiments. Biomedical warming and thawing devices are gaining popularity in research laboratories credited to the associated advantages such as to preserve living cells for a longer duration, reduce the effect of cryopreservatives on the cells, etc. The Rising burden from regulatory authorities for the implementation of effective systems to ensure the viability of cells used for various purposes in research laboratories is further expected to spur the market with lucrative growth opportunities.
Increasing demand for advanced biomedical warming and thawing devices in the China is projected to propel the market revenue
China biomedical warming and thawing devices market size was USD 14 million in 2020 driven by an upsurge in the importance of cryopreservation of blood products & cells and the presence of key market players manufacturing these devices in the country. The market in China is anticipated to expand at a rapid pace during the forecast period owing to a rise in demand for technologically advanced biomedical warming and thawing devices and extensive research activities on blood products. The government of China enacted regulations for the management of blood transfusion and adopted advanced blood preservation technologies to ensure blood safety and sustain blood supply. In 2018, around 63,194 fatalities in traffic accident cases were recorded in the country. As per an article published in 2020, China has made significant advancements in increasing blood donation with a rate of 11 donors per 1,000. Additionally, several industry leaders in the country have introduced a simplified and modern approach in the development of thawing systems, thereby offering a safer and effective device with enhanced outcomes.
Companies are focusing on strategies and launch of innovative products to expand customer base
Some of the major players operating in the market are Brooks Life Sciences, Sartorius AG, Helmer Scientific, Sarstedt AG & Co. KG, Boekel Scientific, Cytiva and Barkey among others. These participants are involved in partnerships, agreement and acquisition to gain an edge over their competitors.